查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1597886

远距药事照护市场：按服务、按应用划分 - 2025-2030 年全球预测

Telepharmacy Market by Services (Pharmacy Consultation, Remote Order Entry), End-Use (Hospitals, Primary Care Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，远距药事照护市场价值为10.4亿美元，预计到2024年将达到11.5亿美元，复合年增长率为10.03%，预计到2030年将达到20.4亿美元。

远距药事照护是远端医疗的一个子集，它透过与偏远地区的患者进行通讯来实现药物护理，从而增强药物管理、患者咨询和配药。这一需求是由于医疗保健需求的增加、获取药房的地理障碍以及对具有成本效益的医疗保健服务的推动而产生的。应用范围从药物治疗管理到慢性病管理再到农村医疗保健支援。远距药事照护的最终用途包括医院、诊所和社区健康中心，是弥合药局服务差距的桥樑。关键的成长要素包括技术进步、远端医疗的广泛采用以及慢性病流行和人口老化推动的对远距医疗解决方案的需求增加。将人工智慧整合到个人化护理、扩大本地医疗网络以及利用巨量资料分析来做出更好的决策等方面存在机会。然而，这个市场面临区域监管差异、资料隐私问题以及虚拟确保製药服务品质的挑战等限制。创新可能集中在开发人工智慧主导的决策支援系统、用于即时监控的行动医疗应用程式以及用于安全资料处理的区块链。与高科技公司合作建立远端医疗平台可以实现无缝的远距药事照护体验。此外，市场是动态的，科技公司、医疗保健系统和创新解决方案新兴企业之间存在着激烈的竞争。战略伙伴关係和对先进远距远端医疗技术的投资对于利用当前的成长势头至关重要。透过倡导统一标准来解决监管障碍可以缓解一些挑战并增强市场进入。总而言之，远距药事照护透过改善医疗保健服务提供了显着的成长途径，但其未来取决于技术整合、不断发展的法规和解决隐私问题，以及促进传统医药保健生态系统的无缝扩展。

主要市场统计
基准年[2023] 10.4亿美元
预测年份 [2024] 11.5亿美元
预测年份 [2030] 20.4亿美元
复合年增长率（%） 10.03%

市场动态：揭示快速发展的远距药事照护市场的关键市场洞察

供需的动态交互作用正在改变远距药事照护市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 远端医疗和远距保健的影响力日益增强
    • 网路用户增加导致网路普及率成长
    • 降低成本和提高业务效率的好处
  • 市场限制因素
    • 远距药事照护相关法律法规的差异
  • 市场机会
    • 增加偏远地区取得基本药物的方法
    • 策略联盟，提供高效率的远距药事照护服务
  • 市场挑战
    • 认知度低且基础设施支援有限

波特五力：驾驭远距远距药事照护市场的策略工具

波特的五力框架是了解远距药事照护市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解远距药事照护市场的外部影响

外部宏观环境因素在塑造远距药事照护市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解远距药事照护市场的竞争状况

对远距药事照护市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵远距远距药事照护市场供应商的绩效评估

FPNV 定位矩阵是评估远距药事照护市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了远距药事照护市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，远距药事照护市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 远端医疗和远端保健的影响力日益增强
      • 网路普及率成长及网路使用者数量增加
      • 降低成本和提高营运效率的好处
    • 抑制因素
      • 远距药事照护相关法律法规的差异
    • 机会
      • 加大力度为偏远地区提供基本药物
      • 策略联盟，提供高效率的远距药事照护服务
    • 任务
      • 认知度低且基础设施支援有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章远距药事照护市场：依服务分类

  • 药局咨询
  • 远程订单输入

第七章远距药事照护市场：依最终用途分类

  • 医院
  • 基层医疗中心

第八章美洲远距药事照护市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区远距远距药事照护市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的远距药事照护市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AMN Healthcare
  • Aspen RxHealth
  • Cardinal Health
  • CPS Solutions, LLC
  • Icebreaker Health, Inc.
  • Medication Review, Inc.
  • Medly Pharmacy
  • MedTel Services
  • Mitsui & Co., Ltd.
  • North West Telepharmacy Solutions
  • NURX Inc.
  • One Touch Telehealth
  • Pipeline Health, LLC
  • PipelineRx
  • Zava
Product Code: MRR-0360AB17E1CA

The Telepharmacy Market was valued at USD 1.04 billion in 2023, expected to reach USD 1.15 billion in 2024, and is projected to grow at a CAGR of 10.03%, to USD 2.04 billion by 2030.

Telepharmacy, a subset of telehealth, enables pharmaceutical care delivery via telecommunications to patients in remote areas, enhancing medication management, patient counseling, and dispensing. Its necessity stems from increasing healthcare demand, geographic barriers to pharmacy access, and the drive for cost-effective health services. Applications are wide-ranging, from medication therapy management to chronic disease management and rural healthcare outreach. End-use spans hospitals, clinics, and community health centers, with telepharmacy serving as a bridge to fill the pharmaceutical care gap. Key growth factors include technological advancements, the proliferation of telemedicine, and rising demand for remote healthcare solutions, spurred by chronic disease prevalence and an aging population. Opportunities lie in the integration of AI to personalize care, expanding rural healthcare networks, and leveraging big data analytics for better decision-making. However, the market faces limitations such as regulatory discrepancies across regions, data privacy concerns, and the challenge of ensuring pharmaceutical service quality virtually. Innovations may focus on developing AI-driven decision support systems, mobile health apps for real-time monitoring, and blockchain for secure data handling. Collaboration with tech companies for integrated telehealth platforms can allow for seamless telepharmacy experiences. Moreover, the market is dynamic, with robust competition among tech firms, healthcare systems, and startups innovating solutions. Strategic partnerships and investments in advanced telehealth technologies are essential to capitalize on current growth momentum. Addressing regulatory hurdles by advocating for uniform standards can mitigate some challenges, enhancing market access. In conclusion, while telepharmacy offers significant growth avenues through enhancing healthcare access, its future will hinge on technological integration, regulatory evolution, and addressing privacy concerns, facilitating its seamless expansion into traditional pharmaceutical care ecosystems.

KEY MARKET STATISTICS
Base Year [2023] USD 1.04 billion
Estimated Year [2024] USD 1.15 billion
Forecast Year [2030] USD 2.04 billion
CAGR (%) 10.03%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Telepharmacy Market

The Telepharmacy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising influence of telemedicine and telehealth
    • Growth in internet penetration coupled with rising internet users
    • Benefits of cost savings and operational efficiencies
  • Market Restraints
    • Differences in laws and regulations related to telepharmacy
  • Market Opportunities
    • Increasing approach to avail the essential drugs in remote areas
    • Strategic alliances to provide efficient telepharmacy services
  • Market Challenges
    • Less awareness and limited infrastructure support

Porter's Five Forces: A Strategic Tool for Navigating the Telepharmacy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Telepharmacy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Telepharmacy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Telepharmacy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Telepharmacy Market

A detailed market share analysis in the Telepharmacy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Telepharmacy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Telepharmacy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Telepharmacy Market

A strategic analysis of the Telepharmacy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Telepharmacy Market, highlighting leading vendors and their innovative profiles. These include AMN Healthcare, Aspen RxHealth, Cardinal Health, CPS Solutions, LLC, Icebreaker Health, Inc., Medication Review, Inc., Medly Pharmacy, MedTel Services, Mitsui & Co., Ltd., North West Telepharmacy Solutions, NURX Inc., One Touch Telehealth, Pipeline Health, LLC, PipelineRx, and Zava.

Market Segmentation & Coverage

This research report categorizes the Telepharmacy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Pharmacy Consultation and Remote Order Entry.
  • Based on End-Use, market is studied across Hospitals and Primary Care Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising influence of telemedicine and telehealth
      • 5.1.1.2. Growth in internet penetration coupled with rising internet users
      • 5.1.1.3. Benefits of cost savings and operational efficiencies
    • 5.1.2. Restraints
      • 5.1.2.1. Differences in laws and regulations related to telepharmacy
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing approach to avail the essential drugs in remote areas
      • 5.1.3.2. Strategic alliances to provide efficient telepharmacy services
    • 5.1.4. Challenges
      • 5.1.4.1. Less awareness and limited infrastructure support
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Telepharmacy Market, by Services

  • 6.1. Introduction
  • 6.2. Pharmacy Consultation
  • 6.3. Remote Order Entry

7. Telepharmacy Market, by End-Use

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Primary Care Centers

8. Americas Telepharmacy Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Telepharmacy Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Telepharmacy Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AMN Healthcare
  • 2. Aspen RxHealth
  • 3. Cardinal Health
  • 4. CPS Solutions, LLC
  • 5. Icebreaker Health, Inc.
  • 6. Medication Review, Inc.
  • 7. Medly Pharmacy
  • 8. MedTel Services
  • 9. Mitsui & Co., Ltd.
  • 10. North West Telepharmacy Solutions
  • 11. NURX Inc.
  • 12. One Touch Telehealth
  • 13. Pipeline Health, LLC
  • 14. PipelineRx
  • 15. Zava

LIST OF FIGURES

  • FIGURE 1. TELEPHARMACY MARKET RESEARCH PROCESS
  • FIGURE 2. TELEPHARMACY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TELEPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TELEPHARMACY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TELEPHARMACY MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TELEPHARMACY MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TELEPHARMACY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TELEPHARMACY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. TELEPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. TELEPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TELEPHARMACY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TELEPHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TELEPHARMACY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TELEPHARMACY MARKET DYNAMICS
  • TABLE 7. GLOBAL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TELEPHARMACY MARKET SIZE, BY PHARMACY CONSULTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TELEPHARMACY MARKET SIZE, BY REMOTE ORDER ENTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TELEPHARMACY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TELEPHARMACY MARKET SIZE, BY PRIMARY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES TELEPHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA TELEPHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM TELEPHARMACY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM TELEPHARMACY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. TELEPHARMACY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. TELEPHARMACY MARKET, FPNV POSITIONING MATRIX, 2023